French drugmaker Sanofi is taking an equity stake worth $180 million in and entering a new strategic collaboration with artificial intelligence (AI) and precision...
15.03.2018
- US-based Kite Pharma, part of Gilead Sciences since October 2017, is collaborating with Sangamo Therapeutics to develop next-generation engineered cell therapies to treat cancer...
20.02.2018
- US Cullinan Oncology, based in Cambridge, MA, and German MAB Discovery (MABD) announced the initiation of a collaboration to develop novel antibody therapeutics based on MABD's...
12.01.2018
- A management reshuffle at the UK’s largest drugmaker, GlaxoSmithKline has caught the market’s attention, especially as it was carried through by closely watched CEO Emma Walmsley...
04.01.2018
- Roche is planning to buy US group Ignyta for around $1.7 billion in an all-cash deal that will expand the Swiss group’s portfolio of cancer medicines. San Diego, California-based...
13.12.2017
- From Jan. 1, 2018, Bayer will streamline its strategic pharmaceutical research and development activities and combine them under a single unit covering the therapeutic areas...
13.11.2017
- Amid estimates that the business could be worth as much as $1.5 billion, speculation is mounting that Swiss drugmaker Novartis may be planning to sell its dermatology generics arm...
02.11.2017
- UK-based Concept Life Sciences, an integrated drug discovery, development and analytical services company, has acquired Scottish contract research organization (CRO) Aquila...
